These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20354958)

  • 1. ST segment elevation during adenosine pharmacological stress testing in a patient with coronary artery disease.
    Raza JA; Khan NU; Mustafa JS; Movahed A
    Am Heart Hosp J; 2009; 7(2):E122-4. PubMed ID: 20354958
    [No Abstract]   [Full Text] [Related]  

  • 2. An example of the clinical selectivity of regadenoson for the A2a adenosine receptor.
    Miyamoto MI; Clarke KA; Thomas GS; Belardinelli L
    Am Heart Hosp J; 2009; 7(2):E118-21. PubMed ID: 20354957
    [No Abstract]   [Full Text] [Related]  

  • 3. Regadenoson in the detection of coronary artery disease.
    Buhr C; Gössl M; Erbel R; Eggebrecht H
    Vasc Health Risk Manag; 2008; 4(2):337-40. PubMed ID: 18561509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chest pain and ST-segment elevation 3 minutes after completion of adenosine pharmacologic stress testing.
    Golzar J; Mustafa SJ; Movahed A
    J Nucl Cardiol; 2004; 11(6):744-6. PubMed ID: 15592198
    [No Abstract]   [Full Text] [Related]  

  • 5. Capturing maximal coronary vasodilation for myocardial perfusion imaging: is timing everything?
    Dilsizian V; Narula J
    JACC Cardiovasc Imaging; 2015 Apr; 8(4):499-500. PubMed ID: 25882579
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging.
    Udelson JE; Heller GV; Wackers FJ; Chai A; Hinchman D; Coleman PS; Dilsizian V; DiCarli M; Hachamovitch R; Johnson JR; Barrett RJ; Gibbons RJ
    Circulation; 2004 Feb; 109(4):457-64. PubMed ID: 14734517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
    Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
    JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regadenoson (CV Therapeutics/Astellas).
    Eggbrecht H; Gössl M
    Curr Opin Investig Drugs; 2006 Mar; 7(3):264-71. PubMed ID: 16555687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regadenoson: review of its established role in myocardial perfusion imaging and emerging applications.
    Palani G; Ananthasubramaniam K
    Cardiol Rev; 2013; 21(1):42-8. PubMed ID: 22643345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regadenoson stress for myocardial perfusion imaging.
    Reyes E
    Future Cardiol; 2016 Jan; 12(1):59-67. PubMed ID: 26639775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine-induced ST segment depression with normal perfusion.
    Hage FG; Heo J; Iskandrian AE
    Cardiol J; 2009; 16(2):121-6. PubMed ID: 19387958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial perfusion imaging laboratory efficiency with the use of regadenoson compared to adenosine and dipyridamole.
    Friedman M; Spalding J; Kothari S; Wu Y; Gatt E; Boulanger L
    J Med Econ; 2013; 16(4):449-60. PubMed ID: 23363331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine-induced coronary vasospasm following drug-eluting stent implantation.
    Matsumoto N; Nagao K; Hirayama A; Kasama S
    BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24518394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varying prognostic significance of "ischemic ST depression" during vasodilator stress testing in patients with normal SPECT/PET myocardial perfusion imaging.
    Piotrowicz R
    Cardiol J; 2009; 16(2):101-4. PubMed ID: 19387955
    [No Abstract]   [Full Text] [Related]  

  • 15. Intermittent ST-segment depressions during adenosine stress test.
    van der Hiel B; Scholte AJ; Stokkel MP
    Clin Nucl Med; 2007 Dec; 32(12):927-9. PubMed ID: 18030042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myocardial infarction during adenosine myocardial perfusion imaging.
    Reyes E; Wechalekar K; Loong CY; Underwood SR
    J Nucl Cardiol; 2004; 11(1):97-9. PubMed ID: 14752479
    [No Abstract]   [Full Text] [Related]  

  • 17. ST Segment Elevation ECG Changes During Pharmacologic Stress With Regadenoson.
    Qamruddin S; Huang HW; Mehra A; Bonyadlou S; Yoon AJ
    Clin Nucl Med; 2016 Jan; 41(1):62-4. PubMed ID: 26447370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current advances in vasodilator pharmacological stress perfusion imaging.
    Druz RS
    Semin Nucl Med; 2009 May; 39(3):204-9. PubMed ID: 19341840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of atrioventricular block with vasodilator stress SPECT: A meta-analysis.
    Andrikopoulou E; Morgan CJ; Brice L; Bajaj NS; Doppalapudi H; Iskandrian AE; Hage FG
    J Nucl Cardiol; 2019 Apr; 26(2):616-628. PubMed ID: 29043556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regadenoson as a new stress agent in myocardial perfusion imaging. Initial experience in The Netherlands].
    Jager PL; Buiting M; Mouden M; Oostdijk AH; Timmer J; Knollema S
    Rev Esp Med Nucl Imagen Mol; 2014; 33(6):346-51. PubMed ID: 24862658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.